Search:
This item requires a subscription.
NICE guidelines will improve the diagnosis and treatment of lung cancer LCIP, Volume 2, Number 1.
The National Institute for Health and Clinical Excellence (NICE) and the National Collaborating Centre for Acute Care (NCC-AC) issued guidance for the NHS in England and Wales for the diagnosis and treatment of lung cancer in February 2005.1 This guideline also updates the NICE technology appraisal guidance No. 26 on the use of docetaxel, paclitaxel, gemcitabine and vinorelbine for the treatment of non-small cell lung cancer (NSCLC), first published in 2001.2
To view this item, select one of the options below:
Purchase access
Sign in
email address
Password
Important
All the articles are in PDF format.
To view the articles you will need Adobe Acrobat Reader.
To download a copy, free of charge, please click here.